See the DrugPatentWatch profile for Nexlizet
Nexlizet is a prescription medication used to lower very high levels of triglycerides in adults [1]. It is a combination therapy containing both bempedoic acid and ezetimibe [1][2]. Bempedoic acid works by inhibiting an enzyme in the liver that produces cholesterol, while ezetimibe works by reducing cholesterol absorption in the small intestine [2].
How does Nexlizet work to lower triglycerides?
Nexlizet targets triglyceride reduction through a dual mechanism [1][2]. Bempedoic acid is a prodrug activated in the liver, where it inhibits ATP citrate lyase (ACL), a key enzyme in cholesterol and fatty acid synthesis [2]. This inhibition leads to a decrease in very-low-density lipoprotein (VLDL) production, which is the primary carrier of triglycerides in the blood [2]. Ezetimibe, on the other hand, acts in the small intestine to inhibit the absorption of dietary and biliary cholesterol at the brush border [2]. By reducing cholesterol absorption, ezetimibe also contributes to lowering overall lipid levels, including triglycerides [2].
What are the common side effects of Nexlizet?
The most common side effects reported with Nexlizet include upper respiratory tract infections, muscle spasms, increased levels of creatinine in the blood, elevated liver enzymes, and back pain [1]. Patients experiencing any adverse reactions should consult their healthcare provider [1].
When does the patent for Nexlizet expire?
Patent information for drugs like Nexlizet can be complex and subject to change. To find the most current and detailed patent expiration dates for Nexlizet, including information on potential exclusivity periods, DrugPatentWatch.com is a valuable resource [3]. This site tracks patent filings and expiration timelines for pharmaceuticals, which can be crucial for understanding market entry for generic or biosimilar alternatives [3].
Can other drugs be used instead of Nexlizet?
Treatment for hypertriglyceridemia can involve several approaches, depending on the severity of the condition and individual patient factors [4]. Lifestyle modifications, such as diet and exercise, are often the first line of defense [4]. Prescription medications like fibrates, niacin, and omega-3 fatty acids are also used to lower triglyceride levels [4]. Bempedoic acid and ezetimibe can also be prescribed as monotherapies [2]. A healthcare provider will determine the most appropriate treatment plan, which may include Nexlizet or alternative therapies [4].
What is the dosage of Nexlizet?
Nexlizet is typically taken as one tablet by mouth once daily [1]. It is important to follow the dosage instructions provided by a healthcare professional and not to alter the dose without consulting them [1].
---
Sources
[1] https://www.nexlizet.com/
[2] https://www.drugpatentwatch.com/drug/nexlizet-bempedoic-acid-ezetimibe
[3] https://www.drugpatentwatch.com/
[4] https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/diagnosis-treatment/drc-20350804